Market Research Logo

Global Transcriptomics Market 2016-2020

Global Transcriptomics Market 2016-2020

About Transcriptomics

Transcriptomics involves the collection and analysis of transcriptomes of different types of cells or tissues present in an organism. The transcriptome characterizes the set of all RNA molecules, which is a part of the genetic code. The difference in genetic expression symbolizes the wide-ranging biochemical and physical differences present among various cells and tissues that may cause genetic disorders.

Technavio’s analysts forecast the global transcriptomics market to grow at a CAGR of 14.10% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global transcriptomics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the transcriptomics consumables, and transcriptomics instruments.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Transcriptomics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Agilent Technologies
  • Illumina
  • Roche Diagnostics
  • Thermo Fisher Scientific
Other prominent vendors
  • Beckman Coulter
  • Becton
  • Dickinson and Company
  • Biological Industries
  • bioMérieux
  • Bio-Rad Laboratories
  • Cepheid
  • Clontech Laboratories
  • Cytognomix
  • Edico Genome
  • Eppendorf
  • Fluidigm
  • GE Healthcare
  • Harvard Bioscience
  • Kapa Biosystems
  • Leica Biosystems
  • Maxim Biotech
  • Molecular Devices
  • Oxford Gene Technology
  • PerkinElmer
  • Promega
  • Qiagen
  • RainDance Technologies
  • Siemens Healthcare
  • Sigma-Aldrich
Market driver
  • Wide range of PCR applications
  • For a full, detailed list, view our report
Market challenge
  • Ethical challenges in stem cell research
  • For a full, detailed list, view our report
Market trend
  • Ethical challenges in stem cell research
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Transcriptomics Market 2016-2020

Technavio recognizes the following companies as the key players in the global transcriptomics market: Agilent Technologies, Illumina, Roche Diagnostics, Thermo Fisher Scientific, Beckman Coulter, Becton, Dickinson and Company, Biological Industries, bioMérieux, Bio-Rad Laboratories, Cepheid, Clontech Laboratories, Cytognomix, Edico Genome, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Leica Biosystems, Maxim Biotech, Molecular Devices, Oxford Gene Technology, PerkinElmer, Promega, Qiagen, RainDance Technologies, Siemens Healthcare, and Sigma-Aldrich.

Commenting on the report, an analyst from Technavio’s team said: “Growing popularity of single cell transcriptomics will be a key trend for market growth. Conventionally, transcriptomics for gene expression measurements were used for bulk sampling that included many cells. However, advances in technology, coupled with the need for specific analysis and results, have driven the need for single cell transcriptomics, which has been extensively used for analyzing rare cell populations such as circulating tumor cells, cancer stem cells in solid tumors, and embryonic stem cells in mammalian blastocysts. Technological advances in single cell transcriptomics have enabled users to carry out live cell imaging and lineage tracing.”

According to the report, one of the key drivers for market growth will be rise in strategic initiatives among vendors. Globally, there has been an increase in strategic initiatives among vendors in the transcriptomics market, which has significantly impacted demand in different regions. Strategic initiatives are primarily to leverage on each other’s USP and that could be a strong customer base, technology, strong financial capability, or R&D capabilities to increase market share and strongly establish presence in the transcriptomics market. For instance, in February 2014, Thermo Fisher (based in the US) acquired Life Technologies for $13.6 billion, which includes business divisions such as sera and media, chromatography instruments, purification consumables, and DNA sequencing. The combination of these two companies will provide access to advance technologies for genomics and proteomics, to accelerate life sciences research. Apart from helping the concerned vendors to expand their respective product portfolios, strategic initiatives have helped global vendors to venture into untapped markets, especially in developing countries, to launch products by leveraging on a local player’s market presence.

Further, the report states that commercialization of transcriptomics products is a challenging process. Some of its products come under the medical devices category as they are used by physicians for diagnostic purposes. The FDA categorizes medical devices, including the ones used for conducting genetic tests (including transcriptomics solutions), into three separate classes, ranging from class I (for relatively low risk products), to class III, (tests are subject to the greatest level of scrutiny). Therefore, they cannot be marketed without successfully completing clinical trials, which is a time consuming, expensive, and uncertain process. The regulations for approval on diagnostics devices vary across countries, which is a major challenge faced by MNCs.

Companies Mentioned

Agilent Technologies, Illumina, Roche Diagnostics, Thermo Fisher Scientific, Beckman Coulter, Becton, Dickinson and Company, Biological Industries, bioMérieux, Bio-Rad Laboratories, Cepheid, Clontech Laboratories, Cytognomix, Edico Genome, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Leica Biosystems, Maxim Biotech, Molecular Devices, Oxford Gene Technology, PerkinElmer, Promega, Qiagen, RainDance Technologies, Siemens Healthcare, and Sigma-Aldrich.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
      • Table Key countries
    • Vendor segmentation
      • Table Global transcriptomics market segmentation: Overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Advantages of transcriptomics
      • Table Key applications of transcriptomics
    • Market size and forecast
      • Table Global transcriptomics market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product type
    • Market overview
      • Table Global transcriptomics market by product type 2015 and 2020
      • Table Global transcriptomics market by product type 2015-2020
    • Global transcriptomics consumables market
      • Table Global transcriptomic consumables market 2015-2020 ($ billions)
    • Global transcriptomics instruments market
      • Table Global transcriptomics instruments market 2015-2020 ($ billions)
  • Market segmentation by technology
    • PCR
      • Table Global transcriptomics market by technology 2015 and 2020
    • NGS
    • RNAi
    • Microarray
  • Market segmentation by PCR technology
    • Market overview
      • Table Global PCR market by technology 2015 and 2020
      • Table Technology lifecycle of PCR 2015
    • qPCR
      • Table Benefits of qPCR technology
    • Standard PCR
    • dPCR
      • Table Benefits of dPCR technology
  • Geographical segmentation
    • Global transcriptomics market by geography
      • Table Global transcriptomics market by geography 2015 and 2020
      • Table Global transcriptomics market by geography 2015-2020
    • Transcriptomics market in Americas
      • Table Transcriptomics market in Americas 2015-2020 ($ billions)
      • Table Export of biopharmaceutical goods from US 2007-2015 ($ billions)
    • Transcriptomics market in EMEA
      • Table Transcriptomics market in EMEA 2015-2020 ($ millions)
      • Table Population over 65 years of age in EMEA
    • Transcriptomics market in APAC
      • Table Transcriptomics market in APAC 2015-2020 ($ millions)
  • Market drivers
    • Table Major chronic disease-related deaths 2012 (in thousands)
    • Table Applications of PCR technology
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Competitive scenario
      • Table Competitive parameters in global transcriptomics market
  • Key Vendor Analysis
    • Agilent Technologies
      • Table Agilent Technologies: Key takeaways
    • Illumina
      • Table Illumina: Key takeaways
    • Roche Diagnostics
      • Table Roche Diagnostics: Key takeaways
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report